Answers are grounded in this paper and cite their sources.
Case report reveals CFTR modulator efficacy in cystic fibrosis, indicating the need for improved treatment access.
This study presents the first report of CFTR modulator efficacy in a Chinese patient, indicating potential treatment benefits. It underscores the urgent need to improve CF awareness, establish a CF genetic mutation database, and expedite CFTR modulator approval/access to promote personalized treatment and outcomes.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: